Sales 2009.

Study characteristics
Methods	Study design: longitudinal cohort Country: Brazil Data collection period: August 2006 – August 2007 Registry ID: N/A (cohort)
Participants	Number of participants: N = 60 Sample characteristics (at baseline): Age (mean): 54 years (SD 10); Sex (% male): 52% (31/60) Population category: chronic physical conditions; Specific population: people with cardiothoracic disease Nicotine dependence: FTND, quitters 5.6, non‐quitters 6.6; Baseline cigarettes per day: 39.2 (SD 19.6); Motivation to quit: selected by motivation to quit
Interventions	Behavioural support for smoking cessation: weekly and bi‐weekly group counselling sessions based on behaviour modification counselling, followed by monthly phone contact after end of group treatment Pharmacological support for smoking cessation: combination of NRT and bupropion recommended Psychotherapeutic or psychoactive support for mental health or mood: did not receive mood management
Outcomes	Definition of cessation used: ‘self‐reported cessation’; reference to 'remaining abstinent' and 'continuously abstinent' Cessation definition used for outcome(s) in this analysis: point‐prevalence abstinence Measure of biovalidation: expired air carbon monoxide (≤ 10 ppm) Definition of people who continued to smoke used: ‘non‐quitters’ (not reported cessation and exhaled CO > 10 ppm) Time point(s) at which follow‐up was conducted: 12 months after baseline Outcome category: Positive Affect; Psychological Quality of Life (QoL) Outcome measure(s): Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36) domains: vitality, mental health and mental component summary
Funding source	None specified
Author conflicts of interest	No declarations specified; however, Maria Penha Uchoa Sales listed as Co‐ordinator of the Smoking Control Program at the Dr Carlos Alberto Studhart Gomes Hospital de Messejana, Fortaleza, Brazil
Notes	Outcome data source: Published data